Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Bevacizumab regimen with fluorouracil, folinic acid and irinotecan
ID: S900005510

Note

  • NCI: A first-line chemotherapy regimen consisting of folinic acid (leucovorin), fluorouracil, irinotecan and bevacizumab used for the treatment of advanced-stage colorectal cancer. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Results Name

  • Bevacizumab regimen with fluorouracil, folinic acid and irinotecan

Name of Substance

  • FOLFIRI-bevacizumab regimen

Synonyms

  • FOLFIRI-bevacizumab
  • Folinic acid-fluorouracil-irinotecan-bevacizumab regimen

Registry Number

  • S900005510